[HTML][HTML] Pathological characteristics of periodontal disease in patients with chronic kidney disease and kidney transplantation

…, Y Obata, K Mitsunari, T Matsuo, K Ohba… - International journal of …, 2019 - mdpi.com
Chronic kidney disease (CKD) is recognized as an irreversible reduction of functional
nephrons and leads to an increased risk of various pathological conditions, including …

[HTML][HTML] Periodontal disease in patients receiving dialysis

…, M Kitamura, K Mitsunari, T Matsuo, K Ohba… - International journal of …, 2019 - mdpi.com
Chronic kidney disease (CKD) is characterized by kidney damage with proteinuria,
hematuria, and progressive loss of kidney function. The final stage of CKD is known as end-stage …

[HTML][HTML] Molecular mechanisms of the anti-cancer effects of isothiocyanates from cruciferous vegetables in bladder cancer

…, T Yuno, Y Mukae, A Otsubo, K Mitsunari, K Ohba… - Molecules, 2020 - mdpi.com
Bladder cancer (BC) is a representative of urological cancer with a high recurrence and
metastasis potential. Currently, cisplatin-based chemotherapy and immune checkpoint inhibitors …

[HTML][HTML] A review of oxidative stress and urinary dysfunction caused by bladder outlet obstruction and treatments using antioxidants

Y Miyata, T Matsuo, K Mitsunari, A Asai, K Ohba… - Antioxidants, 2019 - mdpi.com
Urinary dysfunction is a common pathological condition that can significantly decrease the
quality of life. Bladder outlet obstruction (BOO) is a major cause of urinary dysfunction, and …

[HTML][HTML] High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer

…, Y Sagara, K Mitsunari, T Matsuo, K Ohba… - PLoS …, 2013 - journals.plos.org
Introduction Human antigen R (HuR) regulates the stability of mRNA and is associated with
cell proliferation, angiogenesis, and lymphangiogenesis. However, the clinical significance …

[HTML][HTML] Pharmacological effects and potential clinical usefulness of polyphenols in benign prostatic hyperplasia

K Mitsunari, Y Miyata, T Matsuo, Y Mukae, A Otsubo… - Molecules, 2021 - mdpi.com
Benign prostatic hyperplasia (BPH) is arguably the most common benign disease among
men. This disease is often associated with lower urinary tract symptoms (LUTS) in men and …

[HTML][HTML] Oral intake of royal jelly improves anti‑cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF‑α and TGF‑β in renal …

…, Y Mukai, A Otsubo, K Mitsunari… - Molecular and …, 2020 - spandidos-publications.com
Molecular targeted therapies are commonly used in patients with metastatic renal cell
carcinoma (RCC). However, the efficacy and safety of these therapeutic interventions require …

[HTML][HTML] High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma

…, Y Miyata, T Matsuo, A Asai, K Mitsunari… - … journal of clinical and …, 2014 - ncbi.nlm.nih.gov
Aims: Twist has been reported to play crucial roles for malignant aggressiveness; however,
detailed pathological significance of Twist in renal cell carcinoma (RCC) is not fully …

Progressive and nonprogressive rheumatoid arthritis over a 10-year period in Japan.

K Watanabe, S Urata, K Suzuki, M Ohba… - The Journal of …, 2004 - jrheum.org
We followed 207 patients with rheumatoid arthritis who were registered at our hospital over a
10-year period from between 1989 and 1990. The number of patients who were still treated …

[HTML][HTML] Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of …

M Masato, Y Miyata, H Kurata, H Ito, K Mitsunari… - Scientific Reports, 2021 - nature.com
Prostaglandin E2 plays an important role in carcinogenesis and malignant potential of prostate
cancer (PC) cells by binding to its specific receptors, E-type prostanoid (EP) receptors. …